Development of a decision aid for the treatment of benign prostatic hyperplasia: A four stage method using a Delphi consensus study
Development of a decision aid for the treatment of benign prostatic hyperplasia: A four stage method using a Delphi consensus study
复制标题
DOI：
10.1016/j.pec.2016.02.004
复制
发表时间：
2016-07-01
影响因子：
3.5
通讯作者：
Kil, Paul J. M.
中科院分区：
文献类型：
--
作者：
Lamers, Romy E. D.;Cuypers, Maarten;Kil, Paul J. M.
目的：开发一个基于网络的决策辅助系统（DA），用于治疗良性前列腺增生引起的下尿路症状方法：从2014年2月至9月，我们进行了四个阶段的开发方法：1：泌尿科医生之间的两轮德尔菲共识方法，2：确定患者的需求和期望，3：DA内容和结构的开发，4：结果：1（N = 15）：荷兰泌尿科医生就61%的关于用户标准、决策选项、结构和医疗内容的陈述达成共识。2（N = 24）：69%的人就需要改善信息提供、需要制定DA以及DA应澄清患者偏好的声明达成共识。3：基于第1阶段和第2阶段结果的DA开发。4（N = 10）：优点的DA是明确的信息提供，系统的设计和易于阅读和reread.Conclusion：一个LUTS/BPH DA包含VCE ** 的开发与泌尿科医生和患者的合作，按照结构化的4阶段的方法，并表示被广泛接受。实践意义：这种方法可以通过DA的发展，以支持其他医疗决策问题。(C)2016爱思唯尔爱尔兰有限公司版权所有。
Objective: To develop a web-based decision aid (DA) for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH).Methods: From February-September 2014 we performed a four-stage development method: 1: Two-round Delphi consensus method among urologists, 2: Identifying patients' needs and expectations, 3: Development of DA content and structure, 4: Usability testing with LUTS/BPH patients.Results: 1 (N = 15): Dutch urologists reached consensus on 61% of the statements concerning users' criteria, decision options, structure, and medical content. 2 (N = 24): Consensus was reached in 69% on statements concerning the need for improvement of information provision, the need for DA development and that the DA should clarify patients' preferences. 3: DA development based on results from stage 1 and stage 2. 4 (N = 10): Pros of the DA were clear information provision, systematic design and easy to read and re-read.Conclusion: A LUTS/BPH DA containing VCEs** was developed in cooperation with urologists and patients following a structured 4 stage method and was stated to be well accepted.Practice Implications: This method can be adopted for the development of DAs to support other medical decision issues. (C) 2016 Elsevier Ireland Ltd. All rights reserved.